title: FDG positron emission tomography in patients with systemic mastocytosis.
abstract: OBJECTIVE
  Systemic mastocytosis is a hematologic neoplasm characterized by abnormal accumulation and growth of mast cells in one or more organ systems. We analyzed five patients with systemic mastocytosis referred for FDG positron emission tomography who had biopsy-proven mast cell infiltrates in various organs.
  
  
  CONCLUSIONS
  Our findings indicate that FDG positron emission tomography is not useful for staging and follow-up of aggressive systemic mastocytosis.
authors.affiliation: Department of Nuclear Medicine, University of Vienna, Währinger Gürtel 18-20, A-1090 Wien, Austria.
authors.forename: Georg
authors.initials: G
authors.lastname: Zettinig
authors.forename: Alexander
authors.initials: A
authors.lastname: Becherer
authors.forename: Monika
authors.initials: M
authors.lastname: Szabo
authors.forename: Martin
authors.initials: M
authors.lastname: Uffmann
authors.forename: Robert
authors.initials: R
authors.lastname: Dudczak
authors.forename: Peter
authors.initials: P
authors.lastname: Valent
authors.forename: Kurt
authors.initials: K
authors.lastname: Kletter
mesh_terms: D000328:Adult; D005260:Female; D019788:Fluorodeoxyglucose F18; D006801:Humans; D008297:Male; D008415:Mastocytosis / Q000000981:diagnostic imaging*; D008875:Middle Aged; D009367:Neoplasm Staging; D019275:Radiopharmaceuticals; D014055:Tomography, Emission-Computed
chemical_list: D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18